OverviewSuggest Edit

Syneos Health (formerly known as INC Research) is a contract research organization that provides various clinical development services for the biopharmaceutical and medical device industries. Its operations are divided into two segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers a variety of services spanning clinical development, including clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including deployment solutions, communication solutions, and consulting services.

TypePublic
Founded1998
HQMorrisville, NC, US
Websitesyneoshealth.com
Employee Ratings3.7

Latest Updates

Employees (est.) (Dec 2020)25,000(+5%)
Job Openings1,771
Revenue (FY, 2020)$4.4 B(-5%)
Share Price (Jun 2021)$80.7(-3%)
Cybersecurity ratingCMore

Key People/Management at Syneos Health

Alistair Macdonald

Alistair Macdonald

Chief Executive Officer
Jason Meggs

Jason Meggs

Chief Financial Officer
Neil Ferguson

Neil Ferguson

Chief Business Officer
Michelle Keefe

Michelle Keefe

President, Commercial Solutions
Lisa van Capelle

Lisa van Capelle

Chief Human Resources Officer
Paul Colvin

Paul Colvin

President, Clinical Solutions
Show more

Syneos Health Office Locations

Syneos Health has offices in Morrisville, Austin, Blue Bell, Boston and in 82 other locations
Morrisville, NC, US (HQ)
1030 Sync St
Austin, TX, US
Encino Trace Building II, 5707 Southwest Parkway, Suite 200
Blue Bell, PA, US
1787 Sentry Pkwy W Building 18, Suite 300
Boston, MA, US
470 Atlantic Ave 11th floor
Charlotte, NC, US
11525 N. Community House Road
Irvine, CA, US
2525 Main Street #300
Show all (91)

Syneos Health Financials and Metrics

Syneos Health Revenue

Embed Graph
View revenue for all periods
Syneos Health's revenue was reported to be $4.42 b in FY, 2020 which is a 5.6% decrease from the previous period.
USD

Revenue (Q1, 2021)

1.2b

Gross profit (Q1, 2021)

263.5m

Gross profit margin (Q1, 2021), %

21.8%

Net income (Q1, 2021)

38.7m

EBIT (Q1, 2021)

61.0m

Market capitalization (7-Jun-2021)

8.4b

Closing stock price (7-Jun-2021)

80.7

Cash (31-Mar-2021)

264.7m

EV

11.3b
Syneos Health's current market capitalization is $8.4 b.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

4.4b4.7b4.4b

Revenue growth, %

64%7%(6%)

Cost of goods sold

3.4b3.6b3.4b

Gross profit

955.8m1.0b1.0b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

1.1b1.2b1.2b1.2b1.0b1.1b1.2b

Cost of goods sold

886.8m917.5m913.7m924.0m805.9m820.2m945.3m

Gross profit

232.2m249.3m263.4m239.3m207.5m278.8m263.5m

Gross profit Margin, %

21%21%22%21%20%25%22%
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

155.9m163.7m272.2m

Accounts Receivable

1.3b1.3b1.3m

Current Assets

1.5b1.6b1.7b

PP&E

183.5m203.9m216.2m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

107.9m107.3m129.2m336.0m343.0m248.9m264.7m

Accounts Receivable

1.2b1.3b1.3b1.3b1.2b1.3b

Prepaid Expenses

110.5m

Current Assets

1.4b1.5b1.5b1.8b1.6b1.6b1.7b
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

24.3m131.3m192.8m

Depreciation and Amortization

273.7m242.5m222.4m

Accounts Payable

60.0m28.3m(2.6m)

Cash From Operating Activities

303.4m318.5m425.5m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

(30.0m)(18.7m)40.2m33.6m37.5m100.9m38.7m

Depreciation and Amortization

61.2m121.9m182.1m56.1m112.1m167.6m57.9m

Accounts Payable

(26.7m)32.0m12.3m(66.4m)(64.8m)(2.2m)518.0k

Cash From Operating Activities

(13.3m)83.5m157.9m(38.6m)155.2m311.2m127.1m
USDFY, 2018

EV/EBIT

42 x

EV/CFO

22.2 x

Revenue/Employee

182.9k

Debt/Equity

1 x

Debt/Assets

0.4 x

Financial Leverage

2.5 x

P/E Ratio

171.1
Show all financial metrics

Syneos Health Operating Metrics

Syneos Health's Backlog was reported to be $11b in FY, 2020.
FY, 2018Q1, 2019Q2, 2019Q3, 2019FY, 2019Q1, 2020Q2, 2020Q3, 2020FY, 2020

Countries

474149

Facilities

120110130

Backlog

$4.86 b$7.33 b$8.46 b$8.38 b$8.9 b$9.21 b$9.61 b$9.78 b$10.95 b

Backlog (Clinical Solutions)

$4.32 b$7.61 b$7.83 b$7.78 b$8.22 b$8.55 b$9 b$9.2 b$10.24 b
Show all operating metrics

Syneos Health Acquisitions / Subsidiaries

Company NameDateDeal Size
KinapseAugust 20, 2018
inVentiv Health, Inc.May 10, 2017$4.6 b
Kendle International Inc.May 04, 2011$232 m
inChord Holding Corporation (US)
INC Research Europe
INC Research Holding
INC Research II LP
INC Research International Holdings
inVentiv Clinical UK Entities
inVentiv Commercial Services, LLC
Show more

Syneos Health Revenue Breakdown

Embed Graph

Syneos Health revenue breakdown by business segment: 73.2% from Clinical Solutions, 24.6% from Commercial Solutions and 2.2% from Other

Syneos Health revenue breakdown by geographic segment: 64.7% from North America, 24.6% from Europe, Middle East and Africa and 10.8% from Asia-Pacific

Human Capital Metrics

Embed Graph
Show all human capital metrics

Syneos Health Cybersecurity Score

Cybersecurity ratingPremium dataset

C

75/100

SecurityScorecard logo

Syneos Health Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Syneos Health Online and Social Media Presence

Embed Graph

Syneos Health News and Updates

Syneos Health Launches Patient Voice Consortium

Consortium Advances Behavioral Insights and Diverse Patient Perspectives Across Product Development Lifecycle Consortium Advances Behavioral Insights and Diverse Patient Perspectives Across Product Development Lifecycle

Syneos Health Launches “Lab to Life” Enterprise Partnership with Komodo Health

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced today it has expanded its relationship with Komodo Health, a data-driven healthcare software company with access to the broadest array of real-world data across patients and practitioners.

Syneos Health Launches “Lab to Life” Enterprise Partnership with Komodo Health

Enterprise Partnership Enables Innovative Common Data Foundation Across Clinical, Real-World and Commercial Data by Combining Komodo Health’s Prism and Sentinel Solutions Enterprise Partnership Enables Innovative Common Data Foundation Across Clinical, Real-World and Commercial Data by Combining Kom…

Syneos Health Partners with Medable, Expanding Decentralized Solutions to Bring Clinical Trials Closer to the Patient

New Partnership Leverages Medable’s Patient-Centered Cloud Platform, Accelerating Seamless Real-World Data Capture and Fit-for-Purpose Decentralized Solutions New Partnership Leverages Medable’s Patient-Centered Cloud Platform, Accelerating Seamless Real-World Data Capture and Fit-for-Purpose Decent…

Syneos Health Schedules First Quarter 2021 Earnings Call for Thursday, April 29, 2021

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its first quarter 2021 financial results on Thursday, April 29, 2021, prior to its earnings call at 8:00 a.m. ET.
Show more

Syneos Health Blogs

ICH Q12: Adopting Greater Flexibility in Product Lifecycle Management

Leveraging ICH Q12 tools can add efficiencies, including greater flexibility in managing post-approval changes, in the product lifecycle.

Syneos Health Launches Patient Voice Consortium

Consortium Advances Behavioral Insights and Diverse Patient Perspectives Across Product Development Lifecycle

Streamlined Systems Integration for Data Management, Site Contracting and Investigator Payments Saves Time and Money

SITUATION About the client - top 20 pharmaceutical company Client was maintaining approvals and calculations using their own CTMS (Clinical Trial Management System) while Syneos Health was responsibl

FSP 360 IMS Payment Services Improve Site Satisfaction

SITUATION About the client - mid-tier U.S. biopharmaceutical company conducting: 7 studies 1,800+ sites ~3,600 subjects ~35 countries Studies were large and complex with a global footprint in need o

The Patient Voice Consortium

At Syneos Health, our work and culture have always been fueled by a shared goal of improving the lives of patients. Our Patient Voice Consortium takes this to the next level through a function-agnosti

The Future of Customer Engagement: Adapting Omnichannel in Global Markets

The future of customer engagement and how to prepare for a more globally consistent approach to omnichannel.
Show more

Syneos Health Frequently Asked Questions

  • When was Syneos Health founded?

    Syneos Health was founded in 1998.

  • Who are Syneos Health key executives?

    Syneos Health's key executives are Alistair Macdonald, Jason Meggs and Neil Ferguson.

  • How many employees does Syneos Health have?

    Syneos Health has 25,000 employees.

  • What is Syneos Health revenue?

    Latest Syneos Health annual revenue is $4.4 b.

  • What is Syneos Health revenue per employee?

    Latest Syneos Health revenue per employee is $176.6 k.

  • Who are Syneos Health competitors?

    Competitors of Syneos Health include ICON, PPD and Worldwide Clinical Trials.

  • Where is Syneos Health headquarters?

    Syneos Health headquarters is located at 1030 Sync St, Morrisville.

  • Where are Syneos Health offices?

    Syneos Health has offices in Morrisville, Austin, Blue Bell, Boston and in 82 other locations.

  • How many offices does Syneos Health have?

    Syneos Health has 91 offices.